Market Research Logo

Ensol Biosciences Inc. - Product Pipeline Review - 2016

Ensol Biosciences Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Ensol Biosciences Inc. - Product Pipeline Review - 2016’, provides an overview of the Ensol Biosciences Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Ensol Biosciences Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Ensol Biosciences Inc.
The report provides overview of Ensol Biosciences Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Ensol Biosciences Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Ensol Biosciences Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Ensol Biosciences Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Ensol Biosciences Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Ensol Biosciences Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Ensol Biosciences Inc. Snapshot
Ensol Biosciences Inc. Overview
Key Information
Key Facts
Ensol Biosciences Inc. - Research and Development Overview
Key Therapeutic Areas
Ensol Biosciences Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Ensol Biosciences Inc. - Pipeline Products Glance
Ensol Biosciences Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Ensol Biosciences Inc. - Drug Profiles
Charis-1000
Product Description
Mechanism of Action
R&D Progress
Hesed-1000
Product Description
Mechanism of Action
R&D Progress
Peniel-5000
Product Description
Mechanism of Action
R&D Progress
Amos-1000
Product Description
Mechanism of Action
R&D Progress
Ephphatha-1000
Product Description
Mechanism of Action
R&D Progress
Hesed-2000
Product Description
Mechanism of Action
R&D Progress
Hesed-3000
Product Description
Mechanism of Action
R&D Progress
Hesed-4000
Product Description
Mechanism of Action
R&D Progress
Hesed-5000
Product Description
Mechanism of Action
R&D Progress
Moriah-1000
Product Description
Mechanism of Action
R&D Progress
Shiloah-1000
Product Description
Mechanism of Action
R&D Progress
Ensol Biosciences Inc. - Pipeline Analysis
Ensol Biosciences Inc. - Pipeline Products by Molecule Type
Ensol Biosciences Inc. - Recent Pipeline Updates
Ensol Biosciences Inc. - Dormant Projects
Ensol Biosciences Inc. - Locations and Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Ensol Biosciences Inc., Key Information
Ensol Biosciences Inc., Key Facts
Ensol Biosciences Inc. - Pipeline by Indication, 2016
Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016
Ensol Biosciences Inc. - Monotherapy Products in Pipeline, 2016
Ensol Biosciences Inc. - Out-Licensed Products in Pipeline, 2016
Ensol Biosciences Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Ensol Biosciences Inc. - Preclinical, 2016
Ensol Biosciences Inc. - Discovery, 2016
Ensol Biosciences Inc. - Pipeline by Molecule Type, 2016
Ensol Biosciences Inc. - Recent Pipeline Updates, 2016
Ensol Biosciences Inc. - Dormant Developmental Projects,2016
List of Figures
Ensol Biosciences Inc. - Pipeline by Top 10 Indication, 2016
Ensol Biosciences Inc. - Pipeline by Stage of Development, 2016
Ensol Biosciences Inc. - Monotherapy Products in Pipeline, 2016
Ensol Biosciences Inc. - Out-Licensed Products in Pipeline, 2016
Ensol Biosciences Inc. - Pipeline by Molecule Type, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report